Institution
Danube University Krems
Education•Krems, Niederösterreich, Austria•
About: Danube University Krems is a education organization based out in Krems, Niederösterreich, Austria. It is known for research contribution in the topics: Stroke & Population. The organization has 498 authors who have published 1572 publications receiving 68797 citations.
Papers published on a yearly basis
Papers
More filters
••
TL;DR: Comparison of echocardiographic images with pathoanatomic findings for assessing sensitivity and specificity is urgently needed because of a lack of uniformly accepted standards for measurements.
106 citations
••
TL;DR: Hormone therapy for the primary prevention of chronic conditions in menopausal women is associated with some beneficial effects but also with a substantial increase of risks for harms, and available evidence regarding benefits and harms of early initiation of hormone therapy is inconclusive.
Abstract: Importance Postmenopausal status coincides with increased risks for chronic conditions such as heart disease, osteoporosis, cognitive impairment, or some types of cancers. Previously, hormone therapy was used for the primary prevention of these chronic conditions. Objective To update evidence for the US Preventive Services Task Force on the benefits and harms of hormone therapy in reducing risks for chronic conditions. Data Sources MEDLINE, Cochrane Library, EMBASE, and trial registries from June 1, 2011, through August 1, 2016. Surveillance for new evidence in targeted publications was conducted through July 1, 2017. Study Selection English-language randomized clinical trials reporting health outcomes. Data Extraction and Synthesis Dual review of abstracts, full-text articles, and study quality; meta-analyses when at least 3 similar studies were available. Main Outcomes and Measures Beneficial or harmful changes in risks for various chronic conditions. Results Eighteen trials (n = 40 058; range, 142-16 608; mean age, 53-79 years) were included. Women using estrogen-only therapy compared with placebo had significantly lower risks, per 10 000 person-years, for diabetes (−19 cases [95% CI, −34 to −3]) and fractures (−53 cases [95% CI, −69 to −39]). Risks were statistically significantly increased, per 10 000 person-years, for gallbladder disease (30 more cases [95% CI, 16 to 48]), stroke (11 more cases [95% CI, 2 to 23]), venous thromboembolism (11 more cases [95% CI, 3 to 22]), and urinary incontinence (1261 more cases [95% CI, 880 to 1689]). Women using estrogen plus progestin compared with placebo experienced significantly lower risks, per 10 000 person-years, for colorectal cancer (−6 cases [95% CI, −9 to −1]), diabetes (−14 cases [95% CI, −24 to −3), and fractures (−44 cases [95% CI, −71 to −13). Risks, per 10 000 person-years, were significantly increased for invasive breast cancer (9 more cases [95% CI, 1 to 19]), probable dementia (22 more cases [95% CI, 4 to 53]), gallbladder disease (21 more cases [95% CI, 10 to 34]), stroke (9 more cases [95% CI, 2 to 19]), urinary incontinence (876 more cases [95% CI, 606 to 1168]), and venous thromboembolism (21 more cases [95% CI, 12 to 33]). Conclusions and Relevance Hormone therapy for the primary prevention of chronic conditions in menopausal women is associated with some beneficial effects but also with a substantial increase of risks for harms. The available evidence regarding benefits and harms of early initiation of hormone therapy is inconclusive.
105 citations
••
National Institutes of Health1, Maastricht University Medical Centre2, Umeå University3, Baker IDI Heart and Diabetes Institute4, University of Eastern Finland5, Sheba Medical Center6, Tel Aviv University7, King Abdulaziz University8, Danube University Krems9, AstraZeneca10, University of Helsinki11
TL;DR: Abdominal obesity indicators such as WC, WHR, WSR and WHHR, are stronger predictors for CVD mortality than general obesity indicator of BMI.
Abstract: BACKGROUND/OBJECTIVES: Body mass index (BMI) is the most commonly used surrogate marker for evaluating the risk of cardiovascular disease (CVD) mortality in relation to general obesity, while abdom ...
105 citations
••
TL;DR: In this paper, a brief overview of the background to situated, embodied cognition, present some of its main concepts and conclude with a number of proposals about how findings in this field can be used to further develop research in technical communication and translation studies.
Abstract: This article provides a brief presentation of the development of some cognitive scientific views on technical communication and translation. I look in detail at one of the latest cognitive scientific trends, namely Situated and Embodied Cognition. According to this approach, humans are creative beings who are dependent on their physical and psychological circumstances. I provide a brief overview of the background to situated, embodied cognition, present some of its main concepts and conclude with a number of proposals about how findings in this field can be used to further develop research in Technical Communication and Translation Studies. In doing so, I argue that the new findings in cognitive science will necessarily change some of the common concepts and methodological traditions with regard to the actual text production process and competencies.
105 citations
••
Valparaiso University1, Heidelberg University2, Danube University Krems3, University of São Paulo4, Clínica Alemana5, University of Chile6, Universidad del Desarrollo7, American Heart Association8, Texas Tech University Health Sciences Center at El Paso9, Federal University of São Paulo10, Stroke Association11, Federal University of Bahia12, Pan American Health Organization13, World Health Organization14, National University of Colombia15, Rafael Advanced Defense Systems16, Universidad Autónoma de Nuevo León17, Hospital Punta Pacifica18, Universidad Nacional de Asunción19, Universidad San Francisco de Quito20, The George Institute for Global Health21, Heart and Stroke Foundation of Canada22, Auckland University of Technology23
TL;DR: The meeting culminated with the adoption of the special Gramado Declaration, signed by all Ministerial officials who attended the meeting and an opportunity now exists to translate this Declaration into an action plan to reduce the burden of stroke.
Abstract: Summary The large and increasing burden of stroke in Latin American countries, and the need to meet the UN and WHO requirements for reducing the burden from non-communicable disorders (including stroke), brought together stroke experts and representatives of the Ministries of Health of 13 Latin American countries for the 1st Latin American Stroke Ministerial meeting in Gramado, Brazil, to discuss the problem and identify ways of cooperating to reduce the burden of stroke in the region. Discussions were focused on the regional and country-specific activities associated with stroke prevention and treatment, including public stroke awareness, prevention strategies, delivery and organisation of care, clinical practice gaps, and unmet needs. The meeting culminated with the adoption of the special Gramado Declaration, signed by all Ministerial officials who attended the meeting. With agreed priorities for stroke prevention, treatment, and research, an opportunity now exists to translate this Declaration into an action plan to reduce the burden of stroke.
105 citations
Authors
Showing all 514 results
Name | H-index | Papers | Citations |
---|---|---|---|
Jaakko Tuomilehto | 115 | 1285 | 210682 |
Massimo Zeviani | 104 | 478 | 39743 |
J. Tuomilehto | 69 | 197 | 19801 |
Manfred Reichert | 67 | 695 | 19569 |
Roland W. Scholz | 64 | 289 | 15387 |
Michael Brainin | 55 | 215 | 44194 |
Gerald Gartlehner | 54 | 295 | 15320 |
Thomas Schrefl | 50 | 403 | 10867 |
Charity G. Moore | 50 | 179 | 11040 |
Josef Finsterer | 48 | 1479 | 13836 |
Silvia Miksch | 44 | 264 | 7790 |
J. Tuomilehto | 44 | 107 | 11425 |
Heinrich Schima | 43 | 249 | 5973 |
Reinhard Bauer | 40 | 228 | 5435 |
Thomas Groth | 38 | 186 | 5191 |